• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四物汤抗乳腺癌的预后模型构建及靶点鉴定

Prognostic model construction and target identification of Si-Wu-Tang against breast cancer.

作者信息

Zhang Zeye, Zhang Zexin, Song Jinqin, Wu Wenfeng, Chen Yiqi, Li Jing, Wang Yongchen, Zhao Piwen

机构信息

School of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China.

The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.

出版信息

Heliyon. 2023 Oct 12;9(10):e20709. doi: 10.1016/j.heliyon.2023.e20709. eCollection 2023 Oct.

DOI:10.1016/j.heliyon.2023.e20709
PMID:37876445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10590855/
Abstract

The targets and mechanisms of Si-Wu-Tang (SWT) against (Breast cancer) BRCA were identified and a survival model and nomogram was construted by network pharmacology, bioinformatic analysis and experiments. A total of 72 anti-breast cancer SWT targets were selected, among which eleven genes () were used to construct a novel prognostic model of breast cancer. The anti-breast cancer activity of SWT was related to the modulation of the receptor tyrosine kinases signaling pathways. Moreover, two compounds, mairin and senkyunone were found to bind directly to ITGB3 and RORB proteins. Finally, mRNA and protein expression of ITGB3 and RORB was observed to be significantly down-regulated after incubation of MCF-7 cells with SWT. Overall, our results indicated that mairin and senkyunone were the key ingredients present in SWT, and ITGB3 as well as RORB proteins were the major targets affected by SWT. The prognostic model can be used to predict the outcome of BRCA patients.

摘要

通过网络药理学、生物信息学分析和实验,确定了四物汤(SWT)抗乳腺癌(BRCA)的靶点和机制,并构建了生存模型和列线图。共筛选出72个四物汤抗乳腺癌靶点,其中11个基因用于构建新型乳腺癌预后模型。四物汤的抗乳腺癌活性与受体酪氨酸激酶信号通路的调节有关。此外,发现两种化合物,马里宁和川芎嗪能直接与ITGB3和RORB蛋白结合。最后,在用四物汤处理MCF-7细胞后,观察到ITGB3和RORB的mRNA和蛋白表达显著下调。总体而言,我们的结果表明,马里宁和川芎嗪是四物汤中的关键成分,ITGB3和RORB蛋白是受四物汤影响的主要靶点。该预后模型可用于预测BRCA患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b3/10590855/ed8e0fd585d0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b3/10590855/ed8e0fd585d0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78b3/10590855/ed8e0fd585d0/gr1.jpg

相似文献

1
Prognostic model construction and target identification of Si-Wu-Tang against breast cancer.四物汤抗乳腺癌的预后模型构建及靶点鉴定
Heliyon. 2023 Oct 12;9(10):e20709. doi: 10.1016/j.heliyon.2023.e20709. eCollection 2023 Oct.
2
Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.基于网络药理学结合实验验证的四物汤防治非三阴性乳腺癌多基因调控分子机制的虚拟筛选。
J Ethnopharmacol. 2021 Apr 6;269:113696. doi: 10.1016/j.jep.2020.113696. Epub 2020 Dec 26.
3
Discovery of molecular mechanisms of traditional Chinese medicinal formula Si-Wu-Tang using gene expression microarray and connectivity map.基于基因表达谱芯片和连接图谱技术揭示四物汤的分子作用机制。
PLoS One. 2011 Mar 28;6(3):e18278. doi: 10.1371/journal.pone.0018278.
4
Network and experimental pharmacology on mechanism of Si-Wu-tang improving ovarian function in a mouse model of premature ovarian failure induced by cyclophosphamide.网络与实验药理学研究四物汤改善环磷酰胺诱导的卵巢早衰模型小鼠卵巢功能的作用机制。
J Ethnopharmacol. 2023 Jan 30;301:115842. doi: 10.1016/j.jep.2022.115842. Epub 2022 Oct 18.
5
Evaluating the pharmacological mechanism of Chinese medicine Si-Wu-Tang through multi-level data integration.通过多层次数据整合评估中药四物汤的药理机制。
PLoS One. 2013 Nov 4;8(11):e72334. doi: 10.1371/journal.pone.0072334. eCollection 2013.
6
Transcriptional profiling of Chinese medicinal formula Si-Wu-Tang on breast cancer cells reveals phytoestrogenic activity.转录组学分析四物汤对乳腺癌细胞的影响揭示了其植物雌激素活性。
BMC Complement Altern Med. 2013 Jan 10;13:11. doi: 10.1186/1472-6882-13-11.
7
To Unveil the Molecular Mechanisms of Qi and Blood through Systems Biology-Based Investigation into Si-Jun-Zi-Tang and Si-Wu-Tang formulae.基于系统生物学研究四君子汤和四物汤以揭示气血的分子机制。
Sci Rep. 2016 Sep 28;6:34328. doi: 10.1038/srep34328.
8
Elucidating the pharmacological mechanism by which Si-Wu-Tang induces cellular senescence in breast cancer via multilevel data integration.通过多层次数据整合阐明四物汤诱导乳腺癌细胞衰老的药理机制。
Aging (Albany NY). 2022 Jul 19;14(14):5812-5837. doi: 10.18632/aging.204185.
9
Si-Wu-Tang and its constituents promote mammary duct cell proliferation by up-regulation of HER-2 signaling.四物汤及其成分通过上调HER-2信号促进乳腺导管细胞增殖。
Menopause. 2006 Nov-Dec;13(6):967-76. doi: 10.1097/01.gme.0000227025.96686.8b.
10
Traditional Chinese medicinal formula Si-Wu-Tang prevents oxidative damage by activating Nrf2-mediated detoxifying/antioxidant genes.四物汤通过激活 Nrf2 介导的解毒/抗氧化基因来预防氧化损伤。
Cell Biosci. 2014 Feb 10;4(1):8. doi: 10.1186/2045-3701-4-8.

本文引用的文献

1
Elucidating the pharmacological mechanism by which Si-Wu-Tang induces cellular senescence in breast cancer via multilevel data integration.通过多层次数据整合阐明四物汤诱导乳腺癌细胞衰老的药理机制。
Aging (Albany NY). 2022 Jul 19;14(14):5812-5837. doi: 10.18632/aging.204185.
2
[Phytoestrogen-like effect of Siwu Decoction and molecular mechanism: based on network pharmacology and in vivo experiment].四物汤的类植物雌激素作用及其分子机制:基于网络药理学和体内实验
Zhongguo Zhong Yao Za Zhi. 2022 May;47(10):2750-2758. doi: 10.19540/j.cnki.cjcmm.20211216.704.
3
Ladiratuzumab vedotin for metastatic triple negative cancer: preliminary results, key challenges, and clinical potential.
来迪妥昔单抗(Ladiratuzumab vedotin)用于转移性三阴性乳腺癌:初步结果、关键挑战及临床潜力
Expert Opin Investig Drugs. 2022 Jun;31(6):495-498. doi: 10.1080/13543784.2022.2042252. Epub 2022 Feb 17.
4
Immune-based combinations for metastatic triple negative breast cancer in clinical trials: current knowledge and therapeutic prospects.免疫联合疗法在临床试验中的转移性三阴性乳腺癌:现有知识和治疗前景。
Expert Opin Investig Drugs. 2022 Jun;31(6):557-565. doi: 10.1080/13543784.2022.2009456. Epub 2021 Dec 13.
5
Clinical practice guidelines for modified radical mastectomy of breast cancer: Chinese Society of Breast Surgery (CSBrs) practice guidelines 2021.《乳腺癌改良根治术临床实践指南:中国乳房外科学会(CSBrs)2021年实践指南》
Chin Med J (Engl). 2021 Apr 1;134(8):895-897. doi: 10.1097/CM9.0000000000001412.
6
NR3C2-Related Transcriptome Profile and Clinical Outcome in Invasive Breast Carcinoma.NR3C2 相关转录组谱与浸润性乳腺癌临床结局的关系。
Biomed Res Int. 2021 Jan 28;2021:9025481. doi: 10.1155/2021/9025481. eCollection 2021.
7
miR-301b-3p Regulates Breast Cancer Cell Proliferation, Migration, and Invasion by Targeting NR3C2.miR-301b-3p通过靶向NR3C2调控乳腺癌细胞的增殖、迁移和侵袭。
J Oncol. 2021 Jan 21;2021:8810517. doi: 10.1155/2021/8810517. eCollection 2021.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.乳腺癌的新辅助化疗、内分泌治疗和靶向治疗:ASCO 指南。
J Clin Oncol. 2021 May 1;39(13):1485-1505. doi: 10.1200/JCO.20.03399. Epub 2021 Jan 28.
10
Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.基于网络药理学结合实验验证的四物汤防治非三阴性乳腺癌多基因调控分子机制的虚拟筛选。
J Ethnopharmacol. 2021 Apr 6;269:113696. doi: 10.1016/j.jep.2020.113696. Epub 2020 Dec 26.